Editas Medicine, Inc. (EDIT) dividend history
EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3047% above fair value
$2.14−0.24 (-10.08%)
Close on Nov 12, 2026Market cap $328.66MP/E –Yield –
Dividends
Editas Medicine has not reported a dividend
No dividend per share appears in Editas Medicine's annual filings since fiscal 2013.
See a number that looks wrong?